Cellular basis of triggered arrhythmias in heart failure

Trends in Cardiovascular Medicine

Volumn 14, Issue 2, 2004, Pages 61-66

  Pogwizd, Steven M ^a   Bers, Donald M ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CELL ACTIVITY; CLINICAL TRIAL; ELECTROPHYSIOLOGY; GENE TRANSFER; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; ION CURRENT; ION EXCHANGE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SUDDEN DEATH;

EID: 1542613385     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2003.12.002     Document Type: Review

References (45)

1. Akar F.G., Rosenbaum D.S. Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure. Circ Res. 93:2003;638-645.
2. Altschuld R.A., Starling R.C., Hamlin RLet al. Response of failing canine and human heart cells to beta-2 adrenergic stimulation. Circulation. 92:1995;1612-1618.
3. Anderson K.P., Walker R., Urie Pet al. Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 92:1993;122-140.
4. Baker D.W., Eisenstadter D., Thomas Cet al. Mortality trends for 23,505 Medicare patients hospitalized with heart failure in Northeast Ohio, 1991-1997. Am Heart J. 146:2003;258-264.
5. Bers D.M., Pogwizd S.M., Schlotthauer K. Upregulated Na/Ca exchange is involved in both contractile dysfunction and arrhythmogenesis in heart failure. Basic Res Cardiol. 97(Suppl 1):2002;I-36-I-42.
6. 2+ transport. Circ Res. 93:2003;487-490.
7. Bristow M.R., Ginsburg R., Minobe Wet al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 307:1982;205-211.
8. Carr A.N., Schmidt A.G., Suzuki Yet al. Type I phosphatase, a negative regulator of cardiac function. Mol Cell Biol. 22:2002;4124-4135.
9. Davia K., Bernobich E., Ranu HKet al. SERCA2 overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes. J Mol Cell Cardiol. 33:2001;1005-1015.
10. + concentration is elevated in heart failure, but Na/K pump function is unchanged. Circulation. 105:2002;2543-2548.
11. Ennis I.L., Li R.A., Murphy AMet al. Dual gene therapy with SERCA1 and Kir2.1 abbreviates excitation without suppressing contractility. J Clin Invest. 109:2002;393-400.
12. Gilmour J.R.F., Heger J.J., Prystowsku E.N., Zipes D.P. Cellular electrophysiologic abnormalities of diseased human ventricular myocardium. Am J Cardiol. 51:1983;137-144.
13. Gómez A.M., Guatimosim S., Killy KWet al. Heart failure after myocardial infarction: altered excitation-contraction coupling. Circulation. 104:2001;688-693.
14. 2+-ATPase in failing and nonfailing myocardium. Circ Res. 75:1994;434-442.
15. Hobai I.A., O'Rourke B. Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure. Circulation. 103:2001;1577-1584.
16. Hobai I.A., O'Rourke B. Restoration of Ca handling by Na/Ca exchange blockade in canine pacing-induced heart failure [abst]. Circulation. 106:2002;II-177.
17. 2+ current. Circ Res. 64:1989;977-990.
18. Kaumann A., Bartel S., Molenaar Pet al. Activation of beta-2 adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure. Circulation. 99:1999;65-72.
19. +. Cardiovasc Res. 41:1999;175-187.
20. Luu M., Stevenson W.G., Stevenson LWet al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 80:1989;1675-1680.
21. Marx S.O., Reiken S., Hisamatsu Yet al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 101:2000;365-376.
22. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet. 353:1999;2001-2007.
23. Nuss H.B., Johns D.C., Kääb Set al. Reversal of potassium channel deficiency in cells from failing hearts by adenoviral gene transfer: a prototype for gene therapy for disorders of cardiac excitability and contractility. Gene Ther. 3:1996;900-912.
24. Nuss H.B., Kaab S., Kass DAet al. Cellular basis of ventricular arrhythmias and abnormal automaticity in heart failure. Am J Physiol. 277:1999;H80-H91.
25. O'Rourke B., Kass D.A., Tomaselli GFet al. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ Res. 84:1999;562-570.
26. Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation. 72:1985;681-685.
27. Packer M., Carver J.R., Rodeheffer RJet al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 325:1991;1468-1475.
28. Pak P.H., Nuss H.B., Tunin RSet al. Repolarization abnormalities, arrhythmias and sudden death in canine tachycardia-induced cardiomyopathy. J Am Coll Cardiol. 30:1997;576-584.
29. Piacentino V., Weber C.R., Chen Wet al. Cellular basis of deranged calcium transients of failing human ventricular myocytes. Circulation. 92:2003;651-658.
30. i and contractility in nonfailing and failing human myocardium. Circulation. 106:2002;447-453.
31. Pogwizd S.M. Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits. Circulation. 92:1995;1034-1048.
32. Pogwizd S.M., Hoyt R.H., Saffitz JEet al. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation. 86:1992;1872-1887.
33. Pogwizd S.M., McKenzie J.P., Cain M.E. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation. 98:1998;2404-2414.
34. Pogwizd S.M., Qi M., Yuan Wet al. Upregulation of Na/Ca exchanger expression and function in an arrhythmogenic rabbit model of nonischemic cardiomyopathy. Circ Res. 85:1999;1009-1019.
35. Pogwizd S.M., Schlotthaurer K., Li Let al. Arrhythmogenesis and contractile dysfunction in heart failure. Circ Res. 88:2001;1159-1167.
36. Poole-Wilson P.A., Swedberg K., Cleland JGet al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised control trial. Lancet. 362:2003;7-13.
37. Puglisi J.L., Bers D.M. LabHEART: an interactive computer model of rabbit ventricular myocyte ion channels and Ca transport. Am J Physiol. 281:2001;C2049-C2060.
38. Rector T.S., Cohn J.N. Prognosis in congestive heart failure. Annu Rev Med. 45:1994;341-350.
39. 2+ leak in intact ventricular myocytes from rabbits in heart failure. Circ Res. 93:2003;592-594.
40. 2+ release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes. Circulation. 102:2000;2137-2144.
41. Vermeulen J. Mechanisms of arrhythmias in heart failure. J Cardiovasc Electrophysiol. 9:1998;208-221.
42. Vermeulen J.T., McGuire M.A., Opthof Tet al. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res. 28:1994;1547-1554.
43. Vos M.A., deGroot S.H.M., Berduyn SCet al. Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic complete AV block is related to related to cardiac hypertrophy and electrical remodeling. Circulation. 98:1998;1124-1135.
44. Weber C.R., Ginsburg K.S., Bers D.M. Cardiac submembrane [Na] transients sensed by Na-Ca exchange current. Circ Res. 92:2003;950-952.
45. Wit A.L., Rosen M.R. Afterdepolarizations and triggered activity: distinction from automaticity as an arrhythmogenic mechanism. Fozzard H.A., Haber E., Jennings RBet al. Heart and Cardiovascular System: Scientific Foundations. 2nd ed. 1992;2113-2163 Raven Press, New York.